Tangkitchot, J.; Tantiworawit, A.; Niprapan, P.; Wongsarikan, N.; Srichairatanakool, S.; Punnachet, T.; Hantrakun, N.; Piriyakhuntorn, P.; Rattanathammethee, T.; Chai-Adisaksopha, C.;
et al. Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand. J. Clin. Med. 2025, 14, 3695.
https://doi.org/10.3390/jcm14113695
AMA Style
Tangkitchot J, Tantiworawit A, Niprapan P, Wongsarikan N, Srichairatanakool S, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Chai-Adisaksopha C,
et al. Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand. Journal of Clinical Medicine. 2025; 14(11):3695.
https://doi.org/10.3390/jcm14113695
Chicago/Turabian Style
Tangkitchot, Jirapath, Adisak Tantiworawit, Piangrawee Niprapan, Nuttanun Wongsarikan, Sirichai Srichairatanakool, Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha,
and et al. 2025. "Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand" Journal of Clinical Medicine 14, no. 11: 3695.
https://doi.org/10.3390/jcm14113695
APA Style
Tangkitchot, J., Tantiworawit, A., Niprapan, P., Wongsarikan, N., Srichairatanakool, S., Punnachet, T., Hantrakun, N., Piriyakhuntorn, P., Rattanathammethee, T., Chai-Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., & Hantrakool, S.
(2025). Comparative Clinical Outcomes and Safety of Generic Versus Original Imatinib in the Treatment of Chronic Myeloid Leukemia: A Real-World Cohort Study from Thailand. Journal of Clinical Medicine, 14(11), 3695.
https://doi.org/10.3390/jcm14113695
